Friday, October 11, 2024
HomeNews

News

LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System

LumiraDx Limited, a next-generation point of care diagnostics company, announced that it has achieved CE Mark for the Amira System, its new testing system...

Evidence Partners and Akra Team Form Partnership to Help Medical Device Companies Accelerate the Completion of EU MDR and IVDR Submissions

Evidence Partners Inc., a market leader in AI-enabled literature review automation software and creator of DistillerSR, announced a collaboration with Akra Team, a German-based...

Everest Medicines Announces Approval of Trodelvy in China for Second-Line Metastatic Triple-Negative Breast Cancer

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today...

Landmark Publication Further Validates Approach to Expand the Potential Universe of Cancer-specific Targets by Probing the “Grey Genome”

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, announced a publication in Cell Reports that demonstrates peptides derived from transposable elements (TEs) – mobile...

Amytrx Therapeutic’s AMTX-100 CF3 Moves to Phase II Clinical Trial for Atopic Dermatitis

Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...
0FansLike
0FollowersFollow
spot_img

Hot Topics